2. Company Highlights 2012
We strengthened our position in Russia,
Belarus, Kazakhstan, Uzbekistan and
started operations in Vietnam.
27 new registrations obtained
at export markets.
Persistently developing our R&D expertise
we completed 3 clinical trials, 8 preclinical
trials and 4 trials for veterinary drugs.
We gave a significant emphasis to improvement
of our original products as well as support
to scientific research activity.
Arterium joined
Association of Clinical Trials
Organization in Russia.
3. Company Highlights 2012
We opened next new production
facility for parental solutions
at «Galychpharm», Lviv.
New GMP certificate received
for β-lactam solid forms production
site at «Kievmedpreparat», Kyiv.
With our profound experience
and strong position in implementation
of ERP solutions we extended IFS Application
system to the operations of «Galychpharm».
4. Company Highlights 2012
Arterium joined the Center of Corporate
Social Responsibility Development.
We achieved a leading
position in Transparency
Index among pharmaceutical
companies operating in Ukraine*.
We believe that our CSR project
«Routes of Health» is a good contribution
into promotion of healthy lifestyle
among Ukrainian people.
Play the video
* According to the report of the Center of CSR Development.